Provexis plc risk profile

22 Normal where most of the sector sits

Measured 1 September 2026 from NZCA's filed statements. Recomputed nightly.

22 (Normal), driven by Market expectation at 88, over 3 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation88AcuteStableDrawdown from the 52-week high — 57.5%
Operating pressure1ContainedStableInput-cost exposure — 0.02
Cash conversionReads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company.
Leverage and coverageReads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company.
Competitive position20NormalStableR&D-intensity gap against peers — -69.8 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Provexis plc